Mon, Mar 2, 2015, 7:27 AM EST - U.S. Markets open in 2 hrs 3 mins


% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mr_ssssamsa mr_ssssamsa Oct 14, 2010 12:07 PM Flag


    One more comment about SN-2310. It didn't produce the early-onset diarrhea that's one of the worst side effects of Irinotecan. So if it works, it would probably displace Irinotecan, which as I mentioned has around $1 billion in annual sales, pretty quickly. In preclinical tests it was much more effective than Irinotecan. So even though it didn't show much efficacy in the phase 1 trial, I suspect someone will be interested in licensing it.

2.30+0.01(+0.22%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.